Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2023.03.30
三里枫香：董事会决议公告
2023.03.30
三里枫香：关于续聘会计师事务所的公告
2023.03.30
三里枫香：独立董事候选人关于参加最近一次独立董事培训的书面承诺
2023.03.30
三里枫香：公司章程（2023年3月）
2023.03.30
三里枫香：独立董事年度述职报告
2023.03.30
三里枫香：2022年年度报告摘要
2023.03.30
三里枫香：关于使用自有资金购买理财产品及进行现金管理的公告
2023.03.30
三里枫香：独立董事关于第五届董事会第二十五次会议相关事项之事前认可意见
2023.03.30
三里枫香：独立董事提名人声明（易铭）
2023.03.30
三里枫香：独立董事候选人声明（易铭）
第一页
上一页
13
14
15
16
17
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
